Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lynne M. Vickery‐Clark
Observed names:
L M Vickery-Clark,
L Vickery-Clark,
L. M Vickery-Clark,
L. VICKERY‐CLARK,
L. Vickery-Clark,
L.M. Vickery-Clark,
Lynne M. Vickery-Clark,
Lynne Vickery-Clark
show all 8
OpenAlex ID:
A5085647941
A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.
1994
·
S A Douglas
, C Louden
, et al.
·
Circulation Research
·
197
PDF
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
1987
·
D W Hay
, R M Muccitelli
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
149
Expression of Endothelin-1, Endothelin-3, Endothelin-Converting Enzyme-1, and Endothelin-A and Endothelin-B Receptor mRNA After Angioplasty-Induced Neointimal Formation in the Rat
1996
·
Xinkang Wang
, Stephen A. Douglas
, et al.
·
Circulation Research
·
146
Endothelin‐1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ‐123
1993
·
Stephen A. Douglas
, Lynne M. Vickery‐Clark
, et al.
·
British Journal of Pharmacology
·
49
PDF
Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat
1995
·
S. A Douglas
, L. M Vickery-Clark
, et al.
·
Cardiovascular Research
·
44
Selective Estrogen Receptor Modulator Idoxifene Inhibits Smooth Muscle Cell Proliferation, Enhances Reendothelialization, and Inhibits Neointimal Formation In Vivo After Vascular Injury
2000
·
T.-L. Yue
, L. Vickery-Clark
, et al.
·
Circulation
·
34
Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction
1994
·
Stephen A. Douglas
, Lynne M. Vickery-Clark
, et al.
·
European Journal of Pharmacology
·
25
Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist
1995
·
Nambi Aiyar
, Elayne Baker
, et al.
·
European Journal of Pharmacology
·
20
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
1989
·
T J Torphy
, J F Newton
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
18
Endothelin Receptor Subtypes in the Pathogenesis of Angioplasty-Induced Neointima Formation in the Rat: A Comparison of Selective ETA Receptor Antagonism and Dual ETA/ETB Receptor Antagonism Using BQ-123 and SB 209670
1995
·
Stephen A. Douglas
, Lynne M. Vickery-Clark
, et al.
·
Journal of Cardiovascular Pharmacology
·
16
Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig
1991
·
D.W.P. Hay
, R.M. Muccitelli
, et al.
·
Pulmonary Pharmacology
·
10
Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist.
1987
·
M A Wasserman
, T J Torphy
, et al.
·
PubMed
·
10
ChemInform Abstract: High‐Affinity Leukotriene Receptor Antagonists. Synthesis and Pharmacological Characterization of 2‐Hydroxy‐3‐((2‐carboxyethyl)thio)‐3‐(2‐(8‐ phenyloctyl)phenyl)propanoic Acid.
1987
·
J. G. GLEASON
, R. F. HALL
, et al.
·
ChemInform
Show more works
View as search
Works count:
13
Citation count:
718
H-index:
10
I10-index:
12
Year
Topic
Type